Artiva Biotherapeutics, Inc. Common Stock (ARTV)

5.9

(11.11%)

Total Debt Summary of Artiva Biotherapeutics, Inc. Common Stock

  • Artiva Biotherapeutics, Inc. Common Stock's latest annual total debt in 2023 was 16.91 Million USD , down -13.04% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock's latest quarterly total debt in 2024 Q2 was 15.76 Million USD , down -3.03% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported annual total debt of 19.44 Million USD in 2022, up 1017.06% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported annual total debt of 1.74 Million USD in 2021, down -17.72% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported quarterly total debt of 16.25 Million USD for 2024 Q1, down -3.87% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported quarterly total debt of 16.91 Million USD for 2023 FY, down -13.04% from previous quarter.

Annual Total Debt Chart of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2019)

Historical Annual Total Debt of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2019)

Year Total Debt Total Debt Growth
2023 16.91 Million USD -13.04%
2022 19.44 Million USD 1017.06%
2021 1.74 Million USD -17.72%
2020 2.11 Million USD 0.0%
2019 - USD 0.0%

Peer Total Debt Comparison of Artiva Biotherapeutics, Inc. Common Stock

Name Total Debt Total Debt Difference